A citation-based method for searching scientific literature

G MacGrogan, L Mauriac, M Durand, F Bonichon, M Trojani, I de Mascarel, J M Coindre. Br J Cancer 1996
Times Cited: 170

P Chollet, S Charrier, E Brain, H Curé, I van Praagh, V Feillel, M de Latour, J Dauplat, J L Misset, J P Ferrière. Eur J Cancer 1997
Times Cited: 89

List of shared articles

Times cited

[Neoadjuvant treatment of breast cancer: implications for the pathologist].
Sophie Le Guellec, Romain Perallon, Jean-Philippe Alunni, Hélène Charitansky, Christina Leaha, Aurélie Maran Gonzalez, Marie-Christine Chateau, Joelle Simony-Lafontaine, William Jacot, Marian Gutowski,[...]. Ann Pathol 2011

Impact of tumor biological factors on response to pre-operative epirubicin and paclitaxel chemotherapy in primary breast cancer.
Mathias Warm, Ronald Kates, Peter Mallmann, Michèlle Dick, Frank Nawroth, Nadia Harbeck, Stefan Paepke, Anke Thomas. Anticancer Res 2007

[Place of anatomopathology in evaluation of response to neoadjuvant chemotherapy. Prognostic and predictive markers: example of breast cancer].
Catherine Abrial, Florence Bouchet-Mishellany, Inès Raoelfils, Anne Cayre, Hervé Curé, Philippe Chollet, Frédérique Penault-Llorca. Bull Cancer 2006

[Indications, contra-indications, expected results and choice of neoadjuvant chemotherapy for operable breast cancer].
Marie-Ange Mouret-Reynier, Catherine Abrial, Marianne Leheurteur, Xavier Durando, Isabelle Van Praagh, Pierre Gimbergues, Jean-Louis Achard, Jean-Pierre Ferrière, Hervé Cure, Philippe Chollet. Bull Cancer 2006

Neoadjuvant chemotherapy in breast cancer.
H Charfare, S Limongelli, A D Purushotham. Br J Surg 2005

Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy.
Anne Vincent-Salomon, Alexandra Rousseau, Michel Jouve, Philippe Beuzeboc, Brigitte Sigal-Zafrani, Paul Fréneaux, Christophe Rosty, Claude Nos, François Campana, Jerzy Klijanienko,[...]. Eur J Cancer 2004

Can patients' likelihood of benefiting from primary chemotherapy for breast cancer be predicted before commencement of treatment?
Keith N Ogston, Iain D Miller, Andrew C Schofield, Andreas Spyrantis, Eleni Pavlidou, Tarun K Sarkar, Andrew W Hutcheon, Simon Payne, Steven D Heys. Breast Cancer Res Treat 2004

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome.
I F Faneyte, J G Schrama, J L Peterse, P L Remijnse, S Rodenhuis, M J van de Vijver. Br J Cancer 2003